Rapid Micro Biosystems (NASDAQ:RPID) Cut to “Hold” at Lake Street Capital

Lake Street Capital downgraded shares of Rapid Micro Biosystems (NASDAQ:RPID – Free Report) from a buy rating to a hold rating in a report published on Monday, MarketBeat.com reports. Lake Street Capital currently has $0.75 price target on the stock.

RPID has been the subject of several other reports. JPMorgan Chase & Co. set a $0.75 target price on shares of Rapid Micro Biosystems in a research report on Tuesday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, October 15th. Finally, Roth Capital cut shares of Rapid Micro Biosystems from a “buy” rating to a “neutral” rating and reduced their price target for the company from $3.00 to $0.75 in a research report on Tuesday. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $1.81.

Get Our Latest Stock Report on RPID

Rapid Micro Biosystems Stock Performance

NASDAQ:RPID opened at $0.74 on Monday. The stock has a market cap of $37.00 million, a P/E ratio of -0.68 and a beta of 1.52. The firm’s fifty day simple moving average is $0.89 and its 200 day simple moving average is $2.02. Rapid Micro Biosystems has a twelve month low of $0.58 and a twelve month high of $4.94. The company has a quick ratio of 1.51, a current ratio of 2.55 and a debt-to-equity ratio of 1.08.

Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) last issued its quarterly earnings data on Monday, November 16th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.01). Rapid Micro Biosystems had a negative net margin of 138.24% and a negative return on equity of 211.25%. The company had revenue of $9.53 million for the quarter, compared to analysts’ expectations of $9.85 million. As a group, research analysts predict that Rapid Micro Biosystems will post -0.94 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in RPID. Pekin Hardy Strauss Inc. purchased a new position in Rapid Micro Biosystems during the 3rd quarter valued at about $41,000. Bank of America Corp DE boosted its stake in Rapid Micro Biosystems by 139.9% during the first quarter. Bank of America Corp DE now owns 31,014 shares of the company’s stock worth $70,000 after acquiring an additional 18,085 shares in the last quarter. Renaissance Technologies LLC grew its holdings in Rapid Micro Biosystems by 9.5% in the first quarter. Renaissance Technologies LLC now owns 126,617 shares of the company’s stock worth $287,000 after purchasing an additional 10,990 shares during the period. Sei Investments Co. grew its holdings in Rapid Micro Biosystems by 204.2% in the first quarter. Sei Investments Co. now owns 284,816 shares of the company’s stock worth $647,000 after purchasing an additional 191,200 shares during the period. Finally, Temasek Holdings Private Ltd purchased a new stake in Rapid Micro Biosystems in the first quarter worth about $50,000. Hedge funds and other institutional investors own 52.60% of the company’s stock.

Rapid Micro Biosystems Company Profile

(Get Free Report)

Rapid Micro Biosystems develops automated microbial detection systems for pharmaceutical, biotechnology and other life sciences manufacturers. Its products are designed to support quality-control testing by identifying and measuring microbial growth in manufacturing environments and products. The company’s Growth Direct platform combines laboratory instruments, consumables and software to automate microbial testing. Its applications include sterility testing, bioburden testing and environmental monitoring, helping manufacturers assess contamination during production.

Further Reading

Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.